Theory vs. Conclusion: An Ongoing Issue In Scientific Discussions
According to the CDC, "We are still learning about how the virus spreads and the severity of illness it causes," yet so much information about COVID-19 that we hear in the mainstream media (MSM) and from our Governor, members of the Federal COVID-19 Task Force and popular TV Doctors is presented purely as "fact." Any alternative viewpoints are often dismissed, quieted or suppressed.
Mass Vaccinations During a Pandemic
Geerrt Vanden Bossche, Phd, DVM is an Independent Researcher who previously served as the Head of Vaccine Development for the German Centre for Infection Research, and the Program Manager for the Global Alliance for Vaccines and Immunisation (GAVI) — a collaboration between the World Health Organization, Bill & Melinda Gates Foundation, CDC, and UNICEF. Dr. Bossche also served as the Senior Program Officer of Global Health and Vaccine Discovery for the Bill & Melinda Gates Foundation.
Available COVID-19 Vaccines
According to an article on icandecide.org: Many Americans have been led to believe that a COVID-19 vaccine will prevent individuals from having a serious case of COVID-19 and will stop people from spreading it to others. However, the clinical trials for Pfizer, Moderna, AstraZeneca, and Johnson & Johnson’s products are not designed to determine either of these.
Both Pfizer and Moderna published data suggesting that COVID-19 vaccines might reduce the spread of virus, but the data requires closer scrutiny according to many mainstream media outlets, including Time Magazine.
The FDA has provided emergency use authorization of 3 separate COVID-19 vaccines to date. You can find the latest information about authorization vs. approval at the following address: FDA.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-vaccines
On December 11, 2020, the FDA issued the first emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to be distributed in the U.S. for use in individuals 16 years and older.
On December 18, 2020, the FDA issued the second emergency use authorization (EUA) for the Moderna COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years and older.
On February 27, 2021, the FDA issued the third emergency use authorization (EUA) for the Janssen COVID-19 Vaccine to be distributed in the U.S. for use in individuals 18 years and older.
*Citing insufficient data, the World Health Organization’s latest guidance on Moderna’s COVID vaccine recommends most pregnant women, and anyone under age 18, not get the vaccine. Read more at Pregnant or Under 18? Don’t Get Moderna’s COVID Vaccine, WHO Says • Children's Health Defense
The Johnson & Johnson COVID-19 vaccine is still being tested and does not have emergency use authorization from the FDA. Johnson & Johnson will test its experimental Ad26.COV2.S vaccine on infant children, including newborns, pregnant women and people with compromised immune systems.
ICAN’s legal team, led by Aaron Siri, has taken legal action to challenge employers or schools that require their employees/students to receive a COVID-19 vaccine. In order to obtain this potential assistance: Email ICAN to provide a copy of the written notice from your school or employer stating that the COVID-19 vaccine is required.
Yale researchers identified several specific sex-linked immune system differences that can impact on male susceptibility to severe COVID-19, as well as to female heightened reactivity to COVID-19 vaccination. It appeared that women tended to mount a stronger T-cell response to infection in general. In contrast, men in the early stages of COVID-19 infection showed higher levels of cytokines, inflammatory proteins involved in the “first response” to invading pathogens.
Read the full article at the vaccinereaction.org
More coming to this section soon.
Masks and Mask Mandates
This section is coming soon.
COVID-19 Cases In Michigan
Below is the embedded COVID-19 data widget Powered by Bing.
Please note that the number of recovered cases is not displayed and the daily new cases appears to be cumulative rather than daily. To calculate the death rate of COVID-19 in Michigan, you will need to divide the number of deaths by the number of confirmed cases.